Analysis of survival in patients with 2p gains revealed that all but one patient with 2p gains including MYCN have died for CLL progression or transformation to Richter syndrome (Table II ). In contrast, the two patients harboring 2p gains not including MYCN were alive and treatment free after a follow-up of 88 and 105 months, respectively (Table II) .